P.09.28 ADVERSE REACTIONS OF DIRECT-ACTING ANTIVIRAL AGENTS (DAAS) IN HCV+ PATIENTS. Issue 2 (15th March 2018) - Padovani, D.; Colla, S.; Patti, R.; Buonocore, M.R.; Macor, D.; Lanzilotti, V.; Abazia, C.; Masutti, F.; Parenzan, K.; Schincariol, P.; Crocè, S.L.